BGF, the UK-based venture capital firm, acquired Seda Pharma Development Services Ltd for $15m on March 19, 2026. The transaction aims to accelerate global pharmaceutical growth and secure ownership of Seda's manufacturing facility.
| Acquirer | Target | Value ($M) | Type | Closing Date |
|---|---|---|---|---|
| BGF (GB) | Seda Pharma Development Services Ltd (GB) | 15 | buyout | 2026-03-19 |
The deal includes plans to invest further in business development and support Seda's expansion into international markets. BGF will hold a majority stake in the company, with current shareholders retaining minority positions.
Deal Mechanics
BGF led this investment round without disclosed buy-side or legal advisors. Sell-side advisors for Seda were not announced at the time of closure. Key terms and conditions of the transaction have also been kept confidential.
Strategic Rationale
BGF's investment in Seda is driven by its strategic vision to bolster the company’s manufacturing capabilities and drive global market penetration within the pharmaceutical sector. This move will enable Seda to acquire the freehold of its existing facility, which it previously leased, offering greater operational stability.
Financial Context
Seda Pharma Development Services Ltd has been a leading provider in contract development and manufacturing services for biotech and pharma clients. With this capital injection, the company is poised to enhance its R&D activities and scale up operations across multiple continents.
Advisors
The buy-side advisor was not disclosed by BGF or Seda Pharma Development Services Ltd. Browne Jacobson LLP provided legal advice to shareholders of Seda regarding this transaction, but no information on the buy or sell-side legal counsel has been made public.
Outlook
This acquisition is anticipated to position Seda as a more competitive player in global pharmaceutical markets, leveraging BGF’s financial expertise and industry connections for accelerated growth. The company plans to disclose further details of the strategic roadmap in upcoming communications with stakeholders.